RXRX Recursion Pharmaceuticals, Inc.
Healthcare$3.01-3.22%ClosedMarket Cap: $1.35B
As of 2026-05-25
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
 ARKG | ARK Genomic Revolution ETF | 12,048,498 | 3.62% |
 MOON | Direxion Moonshot Innovators ETF | 42,364 | 1.69% |
 HEAL | Global X - HealthTech ETF | 155,028 | 1.52% |
 ARKK | ARK Innovation ETF | 22,546,454 | 1.21% |
 WTAI FP | 2,206,673 | 0.88% | |
 INTL LN | 2,206,673 | 0.79% | |
 WISE | 77,000 | 0.75% | |
 XBI | 16,732,511 | 0.69% | |
 WDNA LN | 11,039 | 0.61% | |
 WBIO LN | 11,412 | 0.56% | |
 BBC | Virtus Biotech Clinical Trials ETF | 62,975 | 0.54% |
 LABU | Direxion Daily S&P Biotech Bull 3X ETF | 837,939 | 0.53% |
 PWS | Pacer WealthShield ETF | 12,891 | 0.19% |
 TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 12,891 | 0.19% |
 LSLT | Pacer Salt Low truBeta US Market ETF | 12,891 | 0.19% |
 VETS | 12,891 | 0.19% | |
 SLT | Pacer Salt High truBeta US Market ETF | 12,891 | 0.19% |
 VIRS | 12,891 | 0.19% | |
 NUSC | Nuveen ESG Small-Cap | 242,766 | 0.18% |
 HELX | Franklin Genomic Advancements ETF | 10,393 | 0.14% |